Bicara Therapeutics Logo (full size)
Bicara Therapeutics Logo icon/symbol
Bicara Therapeutics Logo (full size) on a dark background
Bicara Therapeutics Logo icon/symbol on a dark background
About Bicara Therapeutics
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.
September 19th, 2024
